![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1557586 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of NAAA mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1557586 | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NAAA mRNA] | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1316359 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of NAAA mRNA | CTD | PMID:20660070 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAAA mRNA | CTD | PMID:32741896 | 17beta-estradiol | increases expression | ISO | RGD:1557586 | 6480464 | Estradiol results in increased expression of NAAA mRNA | CTD | PMID:19484750 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAAA mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NAAA mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAAA mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NAAA mRNA | CTD | PMID:32109520 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:1557586 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NAAA mRNA | CTD | PMID:26251327 | 4,4'-sulfonyldiphenol | decreases expression | ISO | RGD:1557586 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased expression of NAAA mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NAAA mRNA | CTD | PMID:36041667 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1557586 | 6480464 | Fenretinide results in decreased expression of NAAA mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NAAA mRNA | CTD | PMID:24780913 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NAAA mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | decreases expression | ISO | RGD:1316359 | 6480464 | Tretinoin results in decreased expression of NAAA mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | ISO | RGD:1316359 | 6480464 | Antirheumatic Agents results in decreased expression of NAAA mRNA | CTD | PMID:24449571 | arsenous acid | increases expression | ISO | RGD:1316359 | 6480464 | Arsenic Trioxide results in increased expression of NAAA mRNA | CTD | PMID:22521957 | benzene | decreases expression | ISO | RGD:1316359 | 6480464 | Benzene results in decreased expression of NAAA mRNA | CTD | PMID:20036648 | benzo[a]pyrene | decreases expression | ISO | RGD:1557586 | 6480464 | Benzo(a)pyrene results in decreased expression of NAAA mRNA | CTD | PMID:21569818 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1316359 | 6480464 | Diethylhexyl Phthalate results in decreased expression of NAAA mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NAAA mRNA | CTD | PMID:33296240 | bisphenol A | increases expression | ISO | RGD:1557586 | 6480464 | bisphenol A results in increased expression of NAAA mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NAAA mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NAAA mRNA | CTD | PMID:34947998 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NAAA mRNA | CTD | PMID:36041667 | carbon nanotube | affects expression | ISO | RGD:1557586 | 6480464 | Nanotubes, Carbon analog affects the expression of NAAA mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | RGD:1557586 | 6480464 | Nanotubes, Carbon results in decreased expression of NAAA mRNA | CTD | PMID:25554681 | cisplatin | increases expression | ISO | RGD:1316359 | 6480464 | Cisplatin results in increased expression of NAAA mRNA | CTD | PMID:27594783 | copper(II) sulfate | decreases expression | ISO | RGD:1316359 | 6480464 | Copper Sulfate results in decreased expression of NAAA mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | RGD:1316359 | 6480464 | Cyclosporine results in decreased expression of NAAA mRNA | CTD | PMID:20106945, PMID:25562108 | diarsenic trioxide | increases expression | ISO | RGD:1316359 | 6480464 | Arsenic Trioxide results in increased expression of NAAA mRNA | CTD | PMID:22521957 | dibutyl phthalate | decreases expression | ISO | RGD:1557586 | 6480464 | Dibutyl Phthalate results in decreased expression of NAAA mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | RGD:1316359 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAAA mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | RGD:1557586 | 6480464 | epoxiconazole results in decreased expression of NAAA mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | RGD:1557586 | 6480464 | Ethanol results in increased expression of NAAA mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of NAAA mRNA | CTD | PMID:30307764 | folic acid | multiple interactions | ISO | RGD:1557586 | 6480464 | Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of NAAA mRNA] | CTD | PMID:22206623 | folic acid | decreases expression | ISO | RGD:1557586 | 6480464 | Folic Acid results in decreased expression of NAAA mRNA | CTD | PMID:25629700 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of NAAA gene | CTD | PMID:22079235 | furan | decreases methylation | EXP | | 6480464 | furan results in decreased methylation of NAAA gene | CTD | PMID:27387713 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of NAAA mRNA | CTD | PMID:27387713 | genistein | increases expression | ISO | RGD:1316359 | 6480464 | Genistein results in increased expression of NAAA mRNA | CTD | PMID:20884965 | lead diacetate | increases expression | ISO | RGD:1557586 | 6480464 | lead acetate results in increased expression of NAAA mRNA | CTD | PMID:22609695 | methylseleninic acid | decreases expression | ISO | RGD:1316359 | 6480464 | methylselenic acid results in decreased expression of NAAA mRNA | CTD | PMID:18548127 | nickel sulfate | decreases expression | ISO | RGD:1316359 | 6480464 | nickel sulfate results in decreased expression of NAAA mRNA | CTD | PMID:16780908 | potassium chromate | decreases expression | ISO | RGD:1316359 | 6480464 | potassium chromate(VI) results in decreased expression of NAAA mRNA | CTD | PMID:22714537 | progesterone | increases expression | ISO | RGD:1316359 | 6480464 | Progesterone results in increased expression of NAAA mRNA | CTD | PMID:17404688 | progesterone | multiple interactions | ISO | RGD:1316359 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of NAAA mRNA | CTD | PMID:20660070 | SB 431542 | multiple interactions | ISO | RGD:1316359 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAAA mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of NAAA mRNA | CTD | PMID:22431001 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of NAAA mRNA | CTD | PMID:19281266 | sunitinib | increases expression | ISO | RGD:1316359 | 6480464 | Sunitinib results in increased expression of NAAA mRNA | CTD | PMID:31533062 | tacrolimus hydrate | increases expression | ISO | RGD:1557586 | 6480464 | Tacrolimus results in increased expression of NAAA mRNA | CTD | PMID:29362864 | temozolomide | decreases expression | ISO | RGD:1316359 | 6480464 | Temozolomide results in decreased expression of NAAA mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAAA mRNA | CTD | PMID:32741896 | thimerosal | increases expression | ISO | RGD:1316359 | 6480464 | Thimerosal results in increased expression of NAAA mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of NAAA mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of NAAA mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | RGD:1316359 | 6480464 | trichostatin A results in increased expression of NAAA mRNA | CTD | PMID:24935251 | triclosan | decreases expression | ISO | RGD:1316359 | 6480464 | Triclosan results in decreased expression of NAAA mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | RGD:1557586 | 6480464 | triptonide results in increased expression of NAAA mRNA | CTD | PMID:33045310 | valproic acid | increases expression | ISO | RGD:1316359 | 6480464 | Valproic Acid results in increased expression of NAAA mRNA | CTD | PMID:24383497, PMID:26272509 | valproic acid | multiple interactions | ISO | RGD:1316359 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAAA mRNA | CTD | PMID:27188386 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of NAAA mRNA | CTD | PMID:19015723 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of NAAA mRNA | CTD | PMID:23034163 | zinc atom | increases expression | ISO | RGD:1316359 | 6480464 | Zinc deficiency results in increased expression of NAAA mRNA | CTD | PMID:18356318 | zinc(0) | increases expression | ISO | RGD:1316359 | 6480464 | Zinc deficiency results in increased expression of NAAA mRNA | CTD | PMID:18356318 | |